Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis

Exclusion Criteria

• •Individuals who are immune-compromised or suffering from infectious disease, malignant disease, are known to be HIV+ or present with a general reduced level of health.
• •Individuals diagnosed with underlying dermatological conditions in addition to AD.
• •Individuals with a chronic pre-existing disease such as diabetes mellitus or others that in the opinion of the investigator would preclude their participation in the study.
• •Individuals who are pregnant, nursing mothers, or subjects planning a pregnancy during the course of the study.
• •Subjects/caregivers who are unable to communicate or comply with study conditions due to language disability, poor mental development, or impaired cerebral function.
• •Individuals who are simultaneously enrolled in another clinical drug or device research study.
• •Individuals with a history of chronic steroid use.
• •Individuals needing to concurrently use topical agents, medicinal products containing corticosteroids, or immunosuppressants.
• •Individuals who have received systemically administered corticosteroids and/or antihistamines 2 weeks prior to the start of study.
• •Individuals undergoing light therapy.
• •Individuals who have been treated with another investigation device or drug within 30 days prior to study enrollment.
• •Individuals with a known allergy to oregano.